Anti-Human CD217 Recombinant Antibody
-
产品编号
YR1255
-
别名
科研级 Brodalumab ( 布罗达单抗 ), Anti-CD217 Recombinant Antibody, Research Grade Brodalumab
-
规格
- 1mg
- 5mg
Alias | 科研级 Brodalumab ( 布罗达单抗 ), Anti-CD217 Recombinant Antibody, Research Grade Brodalumab |
Catalog Number | YR1255 |
Molecular Name | Brodalumab |
Host | Mouse |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | IgG2 Kappa |
Formulation | PBS, pH7.5 |
Background | Brodalumab (trade name Siliq in the US and Kyntheum in Europe) is a human monoclonal antibody designed for the treatment of inflammatory diseases. In February 2017 it received US FDA approval to treat moderate to severe plaque psoriasis in people who have not improved with other treatments. Use is linked to an increased risk of suicide. |
CAS Number | 1174395-19-7 |
Application | WB, IF, IP, Neut, FuncS, ELISA, FCM |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Target | CD217[Homo sapiens] |